MARKET

TLRY

TLRY

TILRAY BRANDS INC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.850
-0.210
-5.17%
Pre Market: 3.950 +0.1 +2.60% 05:34 08/12 EDT
OPEN
4.180
PREV CLOSE
4.060
HIGH
4.270
LOW
3.850
VOLUME
2.71K
TURNOVER
--
52 WEEK HIGH
14.81
52 WEEK LOW
3.000
MARKET CAP
2.07B
P/E (TTM)
-4.1176
1D
5D
1M
3M
1Y
5Y
Is Most-Watched Stock Tilray Brands, Inc. (TLRY) Worth Betting on Now?
Zacks.com users have recently been watching Tilray Brands, Inc. (TLRY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks · 1d ago
Cronos drives Canadian pot stocks lower after quarterly miss
Cronos Group (NASDAQ:CRON) led a selloff among marijuana compan...
Seekingalpha · 2d ago
'Missouri Marijuana Legalization Initiative Will Appear On November Ballot, State Announces' -Marijuana Moment Report
https://www.marijuanamoment.net/missouri-marijuana-legalization-initiative-will-appear-on-november-ballot-state-announces/
Benzinga · 2d ago
Why Is Curaleaf One Of The Best-Positioned Cannabis Multi-State Operators?
Curaleaf Holdings, Inc. (OTCQX: CURLF) posted its financial results Monday for the second quarter ended June 30, 2022.
Benzinga · 2d ago
Why did Tilray stock jump up today? Compromise on cannabis legislation
The shares of cannabis companies in the U.S. and Canada, including Tilray (TLRY), witnessed an upsurge ...
Seekingalpha · 3d ago
Canopy Growth leads cannabis rally as Senator backs compromise legislation
Cannabis companies in both the U.S. and Canada have traded sharply higher on Monday in a move attributed to the recent remarks made by Sen. Cory Booker on marijuana reforms. Today's cannabis rally comes hours after the Senate Democrats pass...
Seekingalpha · 3d ago
Despite Canopy Growth quarterly results, Canadian cannabis names not trading much lower
Even though Canopy Growth Corp. (NASDAQ:CGC) reported fi...
Seekingalpha · 6d ago
Canopy Growth & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About
As Benzinga Cannabis Capital Conference returns on September 13-14  to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.
Benzinga · 6d ago
More
No Data
Learn about the latest financial forecast of TLRY. Analyze the recent business situations of TILRAY BRANDS INC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 19 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

10.53%Strong Buy
10.53%Buy
63.16%Hold
15.79%Under-perform
0.00%Sell
Analyst Price Target
The average TLRY stock price target is 4.712 with a high estimate of 9.30 and a low estimate of 0.8200.
High9.30
Average4.712
Low0.8200
Current 3.850
EPS
Actual
Estimate
-0.70-0.49-0.29-0.09
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Institutional Holdings
Institutions: 460
Institutional Holdings: 66.00M
% Owned: 14.79%
Shares Outstanding: 536.39M
TypeInstitutionsShares
Increased
109
11.95M
New
57
2.90M
Decreased
81
13.72M
Sold Out
66
5.84M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-1.17%
Pharmaceuticals & Medical Research
-1.16%
Key Executives
Chairman/President/Chief Executive Officer/Director
Irwin Simon
Non-Executive Vice Chairman/Lead Director/Independent Director
Renah Persofsky
Chief Financial Officer
Carl Merton
Other
Denise Faltischek
Other
James Meiers
Director
Brendan Kennedy
Independent Director
Jodi Butts
Independent Director
David Clanachan
Independent Director
John Herhalt
Independent Director
David Hopkinson
Independent Director
Thomas Looney
Independent Director
Walter Robb
No Data
No Data
About TLRY
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: cannabis business, distribution business, beverage alcohol business, and wellness business. The cannabis business segment is engaged in the cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The distribution business segment is engaged in the purchase and resale of pharmaceutical and wellness products. The beverage alcohol business segment is engaged in the production, marketing, and sale of beverage alcohol products. The wellness business segment is engaged in the production, marketing and distribution of hemp-based food and other wellness products. It offers a broad-based portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. It is also a hemp food manufacturer. It has operations in Canada, the United States, Europe, Australia, and Latin America.

Webull offers kinds of Tilray Inc stock information, including NASDAQ:TLRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLRY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TLRY stock methods without spending real money on the virtual paper trading platform.